ARCHIVES

Review Panel: NCI Intramural Program Is Too Large, Redundant, Hierarchical

This article is from The Cancer Letter archive.

Vol. 21 No. 20 | May 19, 1995

Download PDF Visit The Full Archive

Related Articles

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI

May 19, 1989

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

November 8, 2002